[Long-term follow up of therapy-conditioned cerebral changes in acute lymphatic leukemia].
Jung
G
G
Institut und Poliklinik für Radiologische Diagnostik, Universität zu Köln.
Lanfermann
H
H
Benz-Bohm
G
G
Berthold
F
F
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001921:Brain / Q000000981:diagnostic imaging* / Q000187:drug effects / Q000528:radiation effects; D003131:Combined Modality Therapy; D003704:Dementia / Q000139:chemically induced / Q000209:etiology; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007968:Leukoencephalopathy, Progressive Multifocal / Q000139:chemically induced / Q000209:etiology*; D008297:Male; D008727:Methotrexate / Q000009:adverse effects* / Q000627:therapeutic use; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000532:radiotherapy / Q000628:therapy*; D011782:Quadriplegia / Q000139:chemically induced / Q000209:etiology; D011879:Radiotherapy Dosage; D012074:Remission Induction; D013997:Time Factors; D014057:Tomography, X-Ray Computed
D008727:Methotrexate
Langzeitbeobachtung therapiebedingter zerebraler Veränderungen bei akuter lymphatischer Leukämie.